Safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study
Titel:
Safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study
Auteur:
Gaze, Mark N. Handkiewicz-Junak, Daria Hladun, Raquel Laetsch, Theodore W. Sorge, Caryn Sparks, Richard Wan, Simon Ceraulo, Antony Kluczewska-Galka, Aneta Gámez-Cenzano, Cristina States, Lisa J. El Khouli, Riham Aimone, Paola Perraud, Kevin Kollar, Gabor Khanshan, Fariba Blumenstein, Lars Brouri, Fazia Giraudet, Anne-Laure
Verschenen in:
European journal of nuclear medicine and molecular imaging